Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158749 · ClinicalTrials.gov registry record · NA
Generalized and Domain-Specific Episodic Thinking for Smoking Cessation
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Not yet
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT07158749: Clinical Trial NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT07158749 is a NA study that has not yet begun recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158749, a NA study, has not yet begun recruiting, sponsored by Virginia Polytechnic Institute and State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Cigarette smoking remains common, particularly in rural areas, despite ample evidence that smoking causes cancer and respiratory disease. Successful smoking cessation yields the majority of its health benefits (e.g., avoidance of lung cancer) after years of sustained behavioral change; however, people who smoke cigarettes tend to show elevated rates of delay discounting (i.e., devaluation of delayed outcomes) and a bias for immediate gratification. The overall goal of this project is to develop different versions of an episodic future thinking intervention (i.e., visualization of the future) and test their feasibility and efficacy for smoking cessation in rural and urban populations.
Primary Outcome
A timeline followback questionnaire will be used to assess the number of cigarettes smoked per day. Lower values reflect better outcomes.
Interventions
- BEHAVIORAL Episodic Future Thinking (EFT)
- BEHAVIORAL Episodic Recent Thinking (ERT)
- BEHAVIORAL Domain-specific episodic thinking
- BEHAVIORAL Generalized episodic thinking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What is known before NCT07158749 opens enrollment
NCT07158749 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Episodic Future Thinking (EFT) is the first listed.
NCT07158749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07158749 about?
NCT07158749 is a clinical study titled "Generalized and Domain-Specific Episodic Thinking for Smoking Cessation". Cigarette smoking remains common, particularly in rural areas, despite ample evidence that smoking causes cancer and respiratory disease. Successful smoking cessation yields the majority of its health benefits (e.g., avoidance of lung cancer) after years of sustained behavioral change; however, peop...
What is the current status of trial NCT07158749?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2026-05-01. Estimated completion is 2027-05-01.
What interventions are being tested in trial NCT07158749?
The interventions under investigation include: Episodic Future Thinking (EFT) (BEHAVIORAL), Episodic Recent Thinking (ERT) (BEHAVIORAL), Domain-specific episodic thinking (BEHAVIORAL), Generalized episodic thinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07158749?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07158749's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI